Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gensia Automedics was a specialized division of Gensia (later Gensia Sicor) focused on the development and manufacturing of automated drug delivery systems, most notably the EpiPen and other pre-filled syringe technologies. The company played a critical role in the medical device sector by providing reliable, rapid-injection systems for emergency medications. Following the merger of Gensia and Sicor, the entity became part of Gensia Sicor before eventually being integrated into Teva Pharmaceutical Industries through acquisition. Its legacy is primarily tied to its manufacturing expertise in sterile injectable delivery systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gensia Automedics.